CNGB1 Study

A successful gene therapy trialed in a dog model at Michigan State to treat a rare, inherited eye disease has been selected to be advanced to a clinical trial in human patients.
On May 16 at the American Society of Gene and Cell Therapy’s 26th Annual Meeting in Los Angeles, the Foundation for the National Institutes of Health announced that the Accelerating Medicines Partnership® Bespoke Gene Therapy Consortium had selected eight rare diseases for its clinical trial portfolio. Among those selected was retinitis pigmentosa 45.